Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Chemoradiotherapy With Stem Cell Rescue in Relapsed/Refractory Lymphoma
NCT00004907Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Oct 1999
- Primary completion
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan, cyclophosphamide, etoposide in cutaneous T-cell lymphoma (CTCL), Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), sponsored by Northwestern University. Started Oct 1999; status: completed.
02
Drugs
busulfancyclophosphamideetoposide
03
Conditions
cutaneous T-cell lymphoma (CTCL)Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00004907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004907.